Business
Plus Therapeutics signs AI deal with Ephemeral
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Company
Plus Therapeutics
Business
Plus Therapeutics adds SpectronRx for Reyobiq manufacturing
Plus Therapeutics began manufacturing activities and technology transfer with SpectronRx to support late-stage clinical supply of Reyobiq, its rhenium-186 radiopharmaceutical candidate for CNS cancers.